Fig. 2.
- ID
- ZDB-FIG-220104-54
- Publication
- Habjan et al., 2021 - Anti-tuberculosis Compound Screen using a Zebrafish Infection Model identifies an Aspartyl-tRNA Synthetase Inhibitor
- Other Figures
- All Figure Page
- Back to All Figure Page
Screening a library of anti-mycobacterial compounds in zebrafish-infection model identifies 14 hit-compounds. (A) Schematic representation of the screen design. Compounds active against Mtb and M. marinum in vitro were tested in the zebrafish embryo-M. marinum yolk-infection model. (B) Hit compounds were tested in a dose-response assay. Each data point represents the integrated red fluorescence intensity of a single zebrafish embryo, and the signal of each group (10-20 embryos) is expressed as meanąs.e.m. Statistical significance was determined by one-way ANOVA, following Dunnett's multiple comparison test by comparing the signal from the DMSO-treated control sample with each treatment group (*P?0.05, **P?0.01, ***P?0.001, ****P?0.0001). |